SMO and ameloblastoma: Additionally, we reported EGFR mutations and the presence of other gene mutations, including somatic mutations in KRAS, PIK3CA, PTEN, FGFR, CDKN2A, and CTNNB1 on the background of either BRAF or SMO mutation-positive ameloblastomas, occurring exclusively in conventional AMs [9].